FilingReader Intelligence
Dr. Reddy's passes US FDA facility inspection
July 21, 2025 at 03:09 PM UTC•By FilingReader AI
Dr. Reddy's Laboratories announced its API facility in Middleburgh, New York, received a favorable outcome from a US Food & Drug Administration inspection.
The USFDA classified the inspection as 'Voluntary Action Indicated,' meaning no regulatory action is recommended and the inspection is officially closed.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:DRREDDY•Bombay Stock Exchange
News Alerts
Get instant email alerts when Dr. Reddy's Laboratories publishes news
Free account required • Unsubscribe anytime